Sirona Biochem Debt To Equity vs. Shares Outstanding
| SBM Stock | CAD 0.06 0.01 8.33% |
For Sirona Biochem profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Sirona Biochem to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Sirona Biochem Corp utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Sirona Biochem's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Sirona Biochem Corp over time as well as its relative position and ranking within its peers.
Sirona |
Sirona Biochem Corp Shares Outstanding vs. Debt To Equity Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Sirona Biochem's current stock value. Our valuation model uses many indicators to compare Sirona Biochem value to that of its competitors to determine the firm's financial worth. Sirona Biochem Corp is currently regarded as top stock in debt to equity category among its peers. It also is currently regarded as top stock in shares outstanding category among its peers creating about 549,679 of Shares Outstanding per Debt To Equity. Common Stock Shares Outstanding is likely to drop to about 242.2 M in 2024. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Sirona Biochem's earnings, one of the primary drivers of an investment's value.Sirona Shares Outstanding vs. Debt To Equity
Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Sirona Biochem |
| = | 470.90 % |
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Sirona Biochem |
| = | 258.84 M |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Sirona Shares Outstanding Comparison
Sirona Biochem is currently under evaluation in shares outstanding category among its peers.
Sirona Biochem Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Sirona Biochem, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Sirona Biochem will eventually generate negative long term returns. The profitability progress is the general direction of Sirona Biochem's change in net profit over the period of time. It can combine multiple indicators of Sirona Biochem, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Operating Income | -2.2 M | -2.3 M | |
| Net Loss | -2.3 M | -2.4 M | |
| Income Before Tax | -2.3 M | -2.4 M | |
| Total Other Income Expense Net | 72.9 K | 76.5 K | |
| Net Loss | -3.2 M | -3.4 M | |
| Net Loss | -2.3 M | -2.4 M | |
| Income Tax Expense | 6.8 K | 8.5 K | |
| Net Interest Income | -231.9 K | -220.3 K | |
| Interest Income | 46.8 K | 49.1 K | |
| Change To Netincome | 1.9 M | 2 M |
Sirona Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Sirona Biochem. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Sirona Biochem position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Sirona Biochem's important profitability drivers and their relationship over time.
Use Sirona Biochem in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Sirona Biochem position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sirona Biochem will appreciate offsetting losses from the drop in the long position's value.Sirona Biochem Pair Trading
Sirona Biochem Corp Pair Trading Analysis
The ability to find closely correlated positions to Sirona Biochem could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Sirona Biochem when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Sirona Biochem - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Sirona Biochem Corp to buy it.
The correlation of Sirona Biochem is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Sirona Biochem moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Sirona Biochem Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Sirona Biochem can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Sirona Biochem position
In addition to having Sirona Biochem in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Mid Cap ETFs Thematic Idea Now
Mid Cap ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Mid Cap ETFs theme has 70 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Mid Cap ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Sirona Stock Analysis
When running Sirona Biochem's price analysis, check to measure Sirona Biochem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sirona Biochem is operating at the current time. Most of Sirona Biochem's value examination focuses on studying past and present price action to predict the probability of Sirona Biochem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sirona Biochem's price. Additionally, you may evaluate how the addition of Sirona Biochem to your portfolios can decrease your overall portfolio volatility.